The life sciences industry faces significant challenges when it comes to advancing precision drug discovery. The limited availability of multimodal data such as whole genome sequencing with linked deep clinical data can pose a major obstacle in developing new therapies for diseases with unmet needs.

View our on-demand webinar, Linking Genomic and Phenotypic Data to Better Understand the Patient Journey.

Dr. Ed Stepanski, Ovation’s general manager of data, in partnership with Alejandro Zamorano, Datavant’s head of life sciences, partnerships, and business development, explore how to overcome the challenges posed by fragmented and siloed datasets to better provide researchers with linked genomic and phenotypic data.

In this webinar, learn how Ovation and Datavant:

• Leverage Datavant’s common tokenization mechanisms to link Ovation’s deep genomics data to phenotypic data to better characterize populations, identify biomarkers, stratify populations and identify targets
• Advance drug discovery and precision medicine using linked omics and clinical data
• Approached two specific case studies where linking data was required